Contents

Current Pharmaceutical Design, Volume 9 - Number 7

Preface

, 9(7): i

Maurizio Botta


DOI: 10.2174/1381612033391522




Regulation of Angiogenesis by Th1- and Th2-Type Cytokines

, 9(7): 511 - 519

A. Naldini, A. Pucci, C. Bernini and F. Carraro


DOI: 10.2174/1381612033391423




Role of Nitric Oxide in the Modulation of Angiogenesis

, 9(7): 521 - 530

Lucia Morbidelli, Sandra Donnini and Marina Ziche


DOI: 10.2174/1381612033391405




Protein kinases and the Hypoxia-Inducible Factor-1, two switches in angiogenesis

, 9(7): 531 - 541

N. M. Mazure, M. C. Brahimi-Horn and J. Pouysségur


DOI: 10.2174/1381612033391469




Calcium as a Molecular Target in Angiogenesis

, 9(7): 543 - 551

Angela M. Patton, Jareer Kassis, Howard Doong and Elise C. Kohn


DOI: 10.2174/1381612033391559




Heparin Derivatives as Angiogenesis Inhibitors

, 9(7): 553 - 566

M. Presta, D. Leali, H. Stabile, R. Ronca, M. Camozzi, L. Coco, E. Moroni, S. Liekens and M. Rusnati


DOI: 10.2174/1381612033391379




Small-molecule Inhibitors of Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinases (TK)

, 9(7): 567 - 581

Fabrizio Manetti and Maurizio Botta


DOI: 10.2174/1381612033391487




Thrombospondins as Anti-Angiogenic Therapeutic Agents

, 9(7): 583 - 588

Bruno Vailhé and Jean-Jacques Feige


DOI: 10.2174/1381612033391342




Human Tissue Kallikrein: A New Bullet for the Treatment of Ischemia

, 9(7): 589 - 597

Costanza Emanueli and Paolo Madeddu


DOI: 10.2174/1381612033391315




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science